Jasper Therapeutics

About Jasper Therapeutics

Jasper Therapeutics is a biotechnology company focused on targeting mast cells to treat chronic mast cell diseases. Their mission is to develop safer and more effective therapies for patients with chronic mast cell-driven diseases, collaborating with biotech veterans and leading academic institutions.

Products & Services

Briquilimab:A targeted anti-KIT monoclonal antibody designed to deplete mast cells for the treatment of chronic immunological and inflammatory diseases. Currently under evaluation in clinical studies for chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma.

Specialties

Mast Cell Depletion Chronic Mast Cell Diseases Immunological and Inflammatory Diseases

Funding History

No funding data available

This company may be bootstrapped or privately funded

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ronald Martell

Chief Executive Officer

J

Jeet Mahal

Chief Operating Officer

H

Herb Cross

Chief Financial Officer

P

Patricia Carlos

Senior Vice President, Regulatory Affairs & Quality

L

Luca Di Noto

Senior Vice President, Technical Operations

M

Matt Ford

Senior Vice President, Human Resources

View 43 more team members with Pro

Unlock Full Team Directory

Recent News